STOCK TITAN

Braskem (BAK) outlines 2026 earnings release schedule and shareholders’ meeting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K/A

Rhea-AI Filing Summary

Braskem S.A. filed an amended Form 6-K outlining its 2026 corporate events calendar. The company plans to release its quarterly financial statements on May 13, 2026 (1st quarter), August 12, 2026 (2nd quarter), and November 11, 2026 (3rd quarter).

The calendar also sets the Annual Shareholders’ Meeting for April 29, 2026, with the management proposal and call notice scheduled for March 27, 2026. Braskem notes that public meetings with analysts are to be defined, with one date listed as November 12, 2026. The filing includes standard cautionary language on forward-looking statements, highlighting risks related to economic conditions, a geological event in Alagoas, related proceedings, and COVID-19.

Positive

  • None.

Negative

  • None.
Q1 2026 results date May 13, 2026 Scheduled quarterly financial statements – 1st quarter 2026
Q2 2026 results date August 12, 2026 Scheduled quarterly financial statements – 2nd quarter 2026
Q3 2026 results date November 11, 2026 Scheduled quarterly financial statements – 3rd quarter 2026
Annual Shareholders’ Meeting April 29, 2026 Scheduled 2026 Annual Shareholders’ Meeting date
Management proposal submission March 27, 2026 Submission of management proposal and call notice
Analyst meeting date November 12, 2026 Public meetings with analysts to be defined
Form 6-K/A regulatory
"SECURITIES AND EXCHANGE COMMISSION FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER"
Form 6-K/A is an amended report filed with the U.S. Securities and Exchange Commission by a foreign (non‑U.S.) company to correct or add material information previously sent in a Form 6‑K. It matters to investors because it updates the official public record—think of it as a corrected or expanded page in a company’s disclosure file—so the new or corrected details can affect how investors judge the company’s risks, results or future prospects.
Annual Shareholders’ Meeting financial
"Annual Shareholders’ Meeting | 04/29/2026"
A company's annual shareholders’ meeting is a yearly gathering where owners of the company review performance, vote on key decisions (like electing the board or approving executive pay), and ask management questions. Investors care because it’s the main forum to influence how the company is run and to get direct updates—think of it as a town hall where owners judge leaders and set the rules that affect the value of their investment.
Quarterly Financial Statements – ITR financial
"Quarterly Financial Statements – ITR Referring to 1 st quarter | 05/13/2026"
forward-looking statements regulatory
"This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Management Proposal financial
"Submission of the Management Proposal | 03/27/2026"

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K/A

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of May, 2026

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

ANNUAL CALENDAR OF CORPORATE EVENTS

4th version (05/12/2026)

Company Name Braskem S.A.
Responsible for the Investor Relations Area Name: Rosana Cristina Avolio
E-mail: braskem-ri@braskem.com.br
Phone: +55 11 3576-9531
Reference date 2026

 

 

Scheduled dates for periodic and sporadic disclosure of information

 

Annual Financial Statement and Standardized Financial Statement (DFP), as of 12/31/2025 03/26/2026

 

Reference Form for the current fiscal year 05/27/2026

 

Report on the Brazilian Corporate Governance Code – Listed Companies 07/31/2026

 

Quarterly Financial Statements – ITR
Referring to 1st quarter 05/13/2026
Referring to 2nd quarter 08/12/2026
Referring to 3rd quarter 11/11/2026

 

Annual Shareholders’ Meeting
Submission of the Management Proposal 03/27/2026
Submission of the Call Notice 03/27/2026
Annual Shareholders’ Meeting 04/29/2026
Submission of the Minutes of the Annual Shareholders’ Meeting 04/29/2026

 

Public Meetings with Analysts
to be defined 11/12/2026

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 12, 2026

  BRASKEM S.A.
       
       
  By:      /s/     Felipe Montoro Jens
     
    Name: Felipe Montoro Jens
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.


 

 

 

FAQ

What does Braskem (BAK) disclose in this Form 6-K/A?

Braskem S.A. presents its 2026 annual calendar of corporate events, including quarterly earnings release dates and the Annual Shareholders’ Meeting. The filing also reiterates standard forward-looking statement cautions tied to economic conditions, a geological event in Alagoas, and COVID-19 impacts.

When will Braskem (BAK) release its 2026 quarterly results?

Braskem plans to release 2026 quarterly financial statements on May 13 for the first quarter, August 12 for the second quarter, and November 11 for the third quarter. These scheduled dates guide investors on when to expect updated financial information during 2026.

When is Braskem’s 2026 Annual Shareholders’ Meeting scheduled?

Braskem’s 2026 Annual Shareholders’ Meeting is scheduled for April 29, 2026. The company intends to submit the management proposal and call notice on March 27, 2026, and file the meeting minutes on April 29, 2026, providing a clear timetable for corporate governance actions.

Does Braskem (BAK) plan analyst meetings in 2026?

Braskem indicates that public meetings with analysts are to be defined, listing November 12, 2026 as a date in its events calendar. This suggests a planned interaction with the analyst community, complementing the scheduled quarterly financial releases and shareholder meeting activities.

Who is responsible for Braskem’s investor relations in this filing?

The filing identifies Rosana Cristina Avolio as responsible for Braskem’s investor relations area. Contact details include the email address braskem-ri@braskem.com.br and phone number +55 11 3576-9531, providing a direct channel for investor communications and information requests.

What forward-looking risks does Braskem highlight in this document?

Braskem highlights that forward-looking statements are subject to risks from general economic conditions, industry trends, a geological event in Alagoas and related legal proceedings, and COVID-19 impacts. It warns that changes in these factors may cause actual results to differ materially from current expectations.